본문바로가기

DeepDx
Prostate

AI software for prostate cancer


Description
DeepDx Prostate is a clinically validated and CE marked AI diagnostic support software for prostate cancer. The software analyzes digitized slide images of Hematoxylin & Eosin (H&E) stained prostate specimens to detect and localize areas of interest. These areas of interest are detected based on their severity in accordance with the Gleason Scoring System.

Key Features

  • 01

    Approved by Korea MFDS, and CE marked
  • 02

    One Specimen Type
    Needle biopsy, TURP and Prostatectomy (Coming Soon)
  • 03

    Extensively Tested
    500k+ cores analyzed
  • 04

    Versatile Deployment
    Could & On-premise
01AI-based diagnostics support
AI analysis includes ROI detection, Gleason scores, grade group, and quantification of important matrix.
02Fast and Accurate
It takes 30 seconds to run the AI analysis (per core), and improves accuracy with 99% sensitivity and 94% specificity.
03Research-Based
DeepDx Prostate validation studies were published in prestigious peer-reviewed medical journals including Cancers and npj Digital Medicine.
04Consistency
DeepDx Prostate generates Consistency as a diagnostics support software.

Key Functions & Featuress

Colored Overlays
DeepDx Prostate generates three different colored overlays based on the Gleason patterns 3, 4, and 5.

Tumor & Pattern Quantification
The proportions of each Gleason pattern out of the total tumor area and tumor-to-tissue ratios are automatically quantified.

Real-time Modification
Quantitative metrics such as tumor-to-tissue ratios and Gleason pattern ratios are recalculated real-time as annotations are made.

Annotation Tools
Annotation tools allow the user to modify the AI analysis results. Automatic measurements of total tissue and total tumor lengths are also generated.

Matthew Leavitt, MD
PathNet CEO

I can instantly check the results from DeepDx Prostate with a simple click of a button -sometimes revealing small areas of concern that I would have missed had I not had the tool running in the background.

Min-Sun Jin, MD
Bucheon St. Mary's Hospital

In particular, it (DeepDx Prostate) reduces inter-and intra-observer variability. In hospitals without pathology residents, using DeepDx Prostate for screening will allow pathologists to spend more time and energy on their research

Hillel Kahane, MD
StarPath Founder

This tool is very helpful for quality assurance in that it enables the pathologist to re-look at areas that they did not annotate originally, but that the AI algorithm did, and determine if there are additional areas of interest that require their attention

DeepDx Prostate can be used in a variety of use settings including first read, concurrent read, quality control, research and development, and education.